Xilio Therapeutics to transfer listing to Nasdaq Capital Market on Monday
PositiveFinancial Markets
Xilio Therapeutics is set to transfer its listing to the Nasdaq Capital Market on Monday, marking a significant milestone for the company. This move is expected to enhance its visibility and attract more investors, which could lead to increased funding opportunities and growth potential. The transition to a more prestigious exchange reflects the company's commitment to advancing its innovative therapies and expanding its reach in the biotech industry.
— Curated by the World Pulse Now AI Editorial System